The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

被引：2071
作者：
O'Neill, Luke A. J. [1 ]
Bowie, Andrew G. [1 ]
机构：
[1] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland
来源：
NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 05期
基金：
爱尔兰科学基金会;
关键词：
D O I：
10.1038/nri2079
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Signalling by Toll-like receptors (TLRs) involves five adaptor proteins known as MyD88, MAL, TRIF, TRAM and SARM. Recent insights have revealed additional functions for MyD88 apart from NF-kappa B activation, including activation of the transcription factors IRF1, IRF5 and IRF7, and also a role outside the TLRs in interferon-gamma signalling. Biochemical information on MAL and TRAM has shown that both act as bridging adaptors, with MAL recruiting MyD88 to TLR2 and TLR4, and TRAM recruiting TRIF to TLR4 to allow for IRF3 activation. Finally, the function of the fifth adaptor, SARM, has been revealed, which negatively regulates TRIF. These new insights allow for a detailed description of the function of the five TIR-domain-containing adaptors in the initiation of TLR signalling.
引用
收藏
页码：353 / 364
页数：12
相关论文
共 115 条
[1]   Plasmodium berghei infection in mice induces liver injury by an IL-12-and toll-like receptor/myeloid differentiation factor 88-dependent mechanism [J].
Adachi, K ;
Tsutsui, H ;
Kashiwamura, S ;
Seki, E ;
Nakano, H ;
Takeuchi, O ;
Takeda, K ;
Okumura, K ;
Van Kaer, L ;
Okamura, H ;
Akira, S ;
Nakanishi, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5928-5934
[2]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[3]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[4]   Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-κB activation and IFN-β synthesis downstream of Toll-like receptor 3 and 4 [J].
Aksoy, E ;
Vanden Berghe, W ;
Detienne, S ;
Amraoui, Z ;
Fitzgerald, KA ;
Haegeman, G ;
Goldman, M ;
Willems, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (07) :2200-2209
[5]   SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production [J].
An, Huazhang ;
Zhao, Wei ;
Hou, Jin ;
Zhang, Yan ;
Xie, Yun ;
Zheng, Yuejuan ;
Xu, Hongmei ;
Qian, Cheng ;
Zhou, Jun ;
Yu, Yizhi ;
Liu, Shuxun ;
Feng, Gensheng ;
Cao, Xuetao .
IMMUNITY, 2006, 25 (06) :919-928
[6]   A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses [J].
Bartfai, T ;
Behrens, MM ;
Gaidarova, S ;
Pemberton, J ;
Shivanyuk, A ;
Rebek, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7971-7976
[7]   The dsRNA binding site of human toll-like receptor 3 [J].
Bell, Jessica K. ;
Askins, Janine ;
Hall, Pamela R. ;
Davies, David R. ;
Segal, David M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (23) :8792-8797
[8]   The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[9]   ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance [J].
Brint, EK ;
Xu, DM ;
Liu, HY ;
Dunne, A ;
McKenzie, ANJ ;
O'Neill, LAJ ;
Liew, FY .
NATURE IMMUNOLOGY, 2004, 5 (04) :373-379
[10]   Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268
12345678910